Clinical trial NCT05995210: Comparing the Effectiveness of Kinesio Taping and Knee Orthosis in Patients with Patellofemoral Pain Syndrome
Official title: Comparing the Effectiveness of Kinesio Taping and Knee Orthosis in Patients with Patellofemoral Pain Syndrome: a Randomized Controlled Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Patellofemoral Pain Syndrome
Anterior Knee Pain Syndrome
Patellofemoral Pain
Patellofemoral Syndrome
Orthotic Devices
Kinesiotape
Lead sponsor: Istanbul Medipol University Hospital
Sponsor class: OTHER
First posted: 2023-08-16
Enrollment: 54
Sex: ALL
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: prospective randomized controlled single-blind
Primary purpose: SUPPORTIVE_CARE

Brief summary: The aim of the study is to compare the efficacy of kinesio taping treatment and knee orthosis treatment in Patellofemoral Pain Syndrome (PFAS). 54 patients were included in the study and the patients were divided into 3 groups as kinesio taping group (KTG) (n=18), orthotics group (OG) (n=18) and control group (CG) (n=18). A progressive exercise program was applied to all groups and patients were treated 2 days a week for 6 weeks.While kinesio taping was applied to KTG in each session, knee orthosis was given to OG and they were asked to use it for 6 weeks. Visual Analogue Scale (VAS), Kujala Score, Knee injury and Osteoarthritis Outcome Score (KOOS) and isokinetic strength test (IST) were used in the evaluation.

Detailed description: Patients were divided into 3 groups as patellofemoral knee orthosis group, kinesio taping group and control group. Randomization of group allocation was done using the website \&#34;https://www.randomizer.org\&#34;. Patients were unaware of the other group\&#39;s treatment program and group allocation. All participants signed an informed consent form before the study. The primary outcome measure of our study was the Kujala Score, and the secondary outcome measures were the Knee Injury and Osteoarthritis Outcome Score (KOOS), Visual Analog Scale (VAS), quadriceps and hamstring isokinetic muscle strength. The evaluations were performed before and after treatment. All patients were informed about the disease and treatment process before treatment. Patients were informed about the things they should pay attention to for pain management in daily life activities and suggestions were made. In addition, all patients received at least 2 weeks of NSAID treatment by the orthopedist. A progressive exercise program was applied to all treatment groups. The progressive exercise program was continued under the supervision of a physiotherapist 2 days a week for 6 weeks. The progressive exercise program consisted of strengthening exercises for the muscles around the knee and hip, stretching exercises for the hamstring and gastrosoleus muscles. The knee orthosis group received the OrthoCare® 6158 Genucare Luxa knee orthosis. T-max Kinesiology Tape® (Tmax Medical Co., South Korea) brand kinesio tape was used in all patients. In kinesio tape application, 2 Y-shaped tapes were used. The activation technique was applied to the VMO muscle with the first band. In the second band, mechanical correction technique was applied to the patella.

Eligibility criteria: Inclusion Criteria:

* Be between the ages of 18-45
* Patients with a body mass index (BMI) less than 29.9
* Anterior knee pain defined as 3 points on the 10 cm Visual Analogue Scale when performing at least two activities of sitting for a long time, climbing/descending stairs, squatting, running and jumping

Exclusion Criteria:

* Patients with knee osteoarthritis
* History of surgery involving the lower extremity
* Patellar or quadriceps tendinopathy
* Injury to the meniscus or knee ligaments
* Patients showing an allergic response to kinesio tape
* Patients previously treated with PFAS
* Existing hip pathologies
* History of patellar subluxation or dislocation
* Patients with neurological disorders
* Patients who did not fill out the voluntary consent form

Primary outcomes:
measure: Change in baseline Kujala scores of patients treated at week 6
timeFrame: 6 weeks
Secondary outcomes:
measure: Change in baseline Visual Analogue Scale of patients treated at week 6
timeFrame: 6 weeks
measure: Change in baseline Knee Injury and Osteoarthritis Outcome Score of patients treated at week 6
timeFrame: 6 weeks
measure: Change in baseline isokinetic strength test of patients treated at week 6
timeFrame: 6 weeks
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul Medipol University
Study officials:
affiliation: Medipol University
name: Yunus Özdemir, MSc
role: STUDY_CHAIR
References: